Ovid Therapeutics Inc. - stock earnings
OVID Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 3, 2024 BeforeMarket | -0.22 / -0.23 | - | - / 60000 | - |
OVID Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -15.3 million USD | 141562 USD |
| 2023Q3 | -11.3 million USD | 108972 USD |
| 2023Q2 | -12.4 million USD | 75000 USD |
| 2023Q1 | 1.5 billion USD | 66160 USD |
| 2022Q4 | -11.5 million USD | 46280 USD |
| 2022Q3 | -11.1 million USD | 11102 USD |
| 2022Q2 | -14.9 million USD | ? USD |
| 2022Q1 | -16.1 million USD | 1.4 million USD |
| 2021Q4 | -26.0 million USD | -416.3 million USD |
| 2021Q3 | -11.4 million USD | 208383 USD |
| 2021Q2 | -15.8 million USD | 208.4 million USD |
| 2021Q1 | 176.0 million USD | 208.4 million USD |
| 2020Q4 | -22.0 million USD | 5.7 million USD |
| 2020Q3 | -16.4 million USD | 6.9 million USD |
| 2020Q2 | -22.6 million USD | ? USD |
| 2020Q1 | -20.0 million USD | ? USD |
| 2019Q4 | -17.0 million USD | ? USD |
| 2019Q3 | -16.6 million USD | ? USD |
| 2019Q2 | -13.1 million USD | ? USD |
| 2019Q1 | -13.8 million USD | ? USD |
| 2018Q4 | -12.9 million USD | ? USD |
| 2018Q3 | -13.0 million USD | ? USD |
| 2018Q2 | -12.9 million USD | ? USD |
| 2018Q1 | -13.2 million USD | ? USD |
| 2017Q4 | -11.0 million USD | ? USD |
| 2017Q3 | -9.4 million USD | ? USD |
| 2017Q2 | -10.2 million USD | ? USD |
| 2017Q1 | -34.2 million USD | ? USD |
| 2016Q4 | -7.6 million USD | ? USD |
| 2016Q3 | -5.8 million USD | ? USD |
| 2016Q2 | -5.4 million USD | ? USD |
| 2016Q1 | -3.7 million USD | ? USD |
| 2015Q4 | -13.2 million USD | ? USD |
OVID Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -52.3 million USD | 391695 USD |
| 2022 | -51.4 million USD | 1.5 million USD |
| 2021 | 122.8 million USD | 208.4 million USD |
| 2020 | -80.7 million USD | 12.6 million USD |
| 2019 | -59.3 million USD | ? USD |
| 2018 | -52.0 million USD | ? USD |
| 2017 | -64.8 million USD | ? USD |
| 2016 | -22.4 million USD | ? USD |
| 2015 | -13.2 million USD | ? USD |
| 2014 | -446892 USD | ? USD |
OVID
Price: $3.06
52 week price:
Earnings Per Share: -0.74 USD
P/E Ratio: -5.69
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 61100
Ebitda: -9.4 millionMarket Capitalization: 229.8 million